Introducing Spravato: A New Hope for Treatment-Resistant Depression
Introduction
If you’ve been struggling with treatment-resistant depression, you might feel like you’ve run out of options. But Spravato offers a new approach. In this post, we’ll explore what Spravato (Esketamine) is, how it works, and why it’s different from traditional antidepressants.
What is Spravato?
Spravato is an FDA-approved nasal spray for treatment-resistant depression. We’ll explain how it’s used alongside an oral antidepressant and why it’s administered in a clinical setting under supervision.
How Does Spravato Work?
Unlike traditional antidepressants that target serotonin, Spravato works on the glutamate system in the brain, which plays a key role in mood regulation. We’ll break down how this unique approach can offer relief when other treatments haven’t worked.
The Science Behind Esketamine
Esketamine is a form of ketamine, which has been used for decades as an anesthetic. We’ll discuss how scientists discovered its potential for treating depression and why it’s considered a breakthrough for people with TRD.
Who is Spravato For?
Spravato is designed for adults with treatment-resistant depression who have tried at least two other medications without success. We’ll talk about how your doctor determines if Spravato is right for you and what to expect during the evaluation process.
